SCHEMBL20042056

SCHEMBL20042056

CCOC(=O)COc1cc(Nc2nc(C)nc3ccccc23)ccc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 0.53
ABCB1 P08183 9/20 0.53
ABCC1 P33527 6/20 0.53
TP53 P04637 3/20 0.51
SHMT2 P34897 1/20 0.49
MAPT P10636 6/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 2/20 0.49
NPY1R P25929 1/20 0.49
NPY2R P49146 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49
KDM4E B2RXH2 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18088137 0.90 DHFR (0.55) ABCG2ABCB1ABCC1TP53SHMT2
SCHEMBL18088136 0.83 TP53 (0.59) TP53MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL2256504 0.83 ABCG2 (0.73) ABCG2ABCB1ABCC1TP53MAPT
SCHEMBL20042356 0.80 ABCB1 (0.48) ABCG2ABCB1ABCC1TP53SHMT2
SCHEMBL18088094 0.78 HDAC1 (0.68) MAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL29126710 0.78 ABCG2 (0.61) ABCG2ABCB1ABCC1TP53MAPT
SCHEMBL29126705 0.77 ABCG2 (0.53) ABCG2ABCB1ABCC1TP53MAPT
SCHEMBL18088085 0.76 TP53 (0.57) TP53MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL3109746 0.75 ABCG2 (0.74) ABCG2ABCB1ABCC1TP53MAPT
SCHEMBL29126698 0.75 CYP1A2 (0.66) ABCG2ABCB1ABCC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF HDAC1, HDAC5, HDAC9 ABCG2 198/4885ABCB1 1390/4885ABCC1 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.